Recently, ACMR was featured in an article about Lewy body dementia for The Atlanta Journal-Constitution, the major daily newspaper in the metropolitan area of Atlanta, Georgia.
Commonly called LBD this relatively unknown disease received a spike in media attention after famous Atlantan, Ted Turner announced he was diagnosed with Lewy body dementia in 2018. The article’s writer, Rodney Ho, highlighted the broad lack of awareness for LBD, the second common type of dementia behind Alzheimer’s disease. The article explained how it is commonly misdiagnosed and differences between LBD and other memory-impairment disorders such as Alzheimer's Disease and Parkinson's Disease. It also shared the perspectives of patients suffering from LBD and family members who have recently lost loved ones to it.
As the number of Americans impacted by LBD continues to grow (approximately 1.4 million), pharmaceutical companies are now starting to invest in more funding into dementia research. The article featured ACMR’s founder, Dr. Robert Riesenberg and his experience with LBD research. Due to a lack of testing to identify the condition, Dr. Riesenberg stated that finding a cure is very challenging. Another challenge Dr. Riesenberg spoke of is finding volunteers to participate in LBD medical research.
A volunteer has to be a giving person, Dr. Riesenberg explained.
They might receive a placebo and not even receive the drug.
Riesenberg shared that
dementia research is still in its relative infancy. However, as awareness of this disease grows, Dr. Riesenberg expects more resources, including study volunteers and funding, to be available for research on medications to help with symptoms and possibly a cure for this disease. Currently, the center has two clinical trials connected to Lewy Body Dementia research.